Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$48M |
| 2 |
American Electric Power
AEP
|
+$40.9M |
| 3 |
Comcast
CMCSA
|
+$38.2M |
| 4 |
Entergy
ETR
|
+$30.6M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$27.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$378M |
| 2 |
Amazon
AMZN
|
+$336M |
| 3 |
Apple
AAPL
|
+$294M |
| 4 |
Alibaba
BABA
|
+$258M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$136M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.92% |
| 2 | Consumer Discretionary | 8.02% |
| 3 | Utilities | 7.46% |
| 4 | Healthcare | 7.42% |
| 5 | Financials | 7.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DVAX
1101
DELISTED
Dynavax Technologies
DVAX
| $745K | 0.01% |
+75,739
| New | +$624K |
|
|
AAQC.U
1102
DELISTED
Accelerate Acquisition Corp Units
AAQC.U
| $745K | 0.01% |
+75,000
| New | +$740K |
|
1103
Upbound Group
UPBD
$1.12B
| $744K | 0.01% |
12,909
-1,349
| -9% | -$70.6K |
|
1104
Coherus Oncology
CHRS
$210M
| $741K | 0.01% |
+50,716
| New | +$861K |
|
1105
Cohu
COHU
$2.43B
| $741K | 0.01% |
+17,716
| New | +$780K |
|
1106
SLR Investment Corp
SLRC
$693M
| $741K | 0.01% |
+41,721
| New | +$765K |
|
1107
Commault Systems
CVLT
$5.43B
| $735K | 0.01% |
11,400
+2,824
| +33% | +$179K |
|
|
UNIT
1108
Uniti Group
UNIT
$2.39B
| $734K | 0.01% |
+66,586
| New | +$803K |
|
|
BHR
1109
Braemar Hotels & Resorts
BHR
$141M
| $733K | 0.01% |
120,722
+85,516
| +243% | +$502K |
|
|
TRVN
1110
DELISTED
Trevena, Inc.
TRVN
| $733K | 0.01% |
655
+260
| +66% | +$359K |
|
1111
Core Laboratories
CLB
$553M
| $732K | 0.01% |
+25,419
| New | +$868K |
|
1112
Carvana
CVNA
$79.5B
| $728K | 0.01% |
+13,880
| New | +$765K |
|
1113
Opendoor
OPEN
$3.33B
| $728K | 0.01% |
35,491
-140,980
| -80% | -$3.72M |
|
1114
Golub Capital BDC
GBDC
$3.44B
| $727K | 0.01% |
+49,707
| New | +$731K |
|
1115
Mondelez International
MDLZ
$82.6B
| $726K | 0.01% |
12,396
-16,571
| -57% | -$935K |
|
1116
Leidos
LDOS
$17.4B
| $725K | 0.01% |
+7,525
| New | +$760K |
|
1117
Twist Bioscience
TWST
$8.83B
| $725K | 0.01% |
+5,850
| New | +$888K |
|
1118
Royalty Pharma
RPRX
$27.3B
| $724K | 0.01% |
+16,596
| New | +$787K |
|
1119
HEICO Corp
HEI
$49.3B
| $722K | 0.01% |
+5,739
| New | +$737K |
|
|
NP
1120
DELISTED
Neenah, Inc. Common Stock
NP
| $722K | 0.01% |
+14,059
| New | +$781K |
|
1121
Neuronetics
STIM
$220M
| $721K | 0.01% |
58,263
+28,675
| +97% | +$440K |
|
1122
Federal Realty Investment Trust
FRT
$10.2B
| $719K | 0.01% |
7,084
+2,126
| +43% | +$205K |
|
1123
Lazard
LAZ
$4.29B
| $718K | 0.01% |
16,508
-26,198
| -61% | -$1.11M |
|
|
GES
1124
DELISTED
Guess Inc
GES
| $717K | 0.01% |
30,508
-5,952
| -16% | -$147K |
|
|
HTO
1125
H2O America
HTO
$2.7B
| $714K | 0.01% |
11,340
-21,529
| -65% | -$1.41M |
|
Similar funds
Michael Gelband's Q1 2021 Portfolio in Review
As of Q1 2021, Michael Gelband held 2,871 positions worth $6.86B, down 33% from $10.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Michael Gelband withdrew a net $3.78B in Q1 2021, closing 811 positions and reducing 524 holdings. Its most notable exit was Alibaba, an estimated $258M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Utilities.
Against the trend, Michael Gelband opened a new position in Comcast worth $39.1M.
- Michael Gelband's largest Q1 2021 buy was Comcast: 722,523 shares worth $39.1M.
- Michael Gelband added most to iShares Russell 1000 Value ETF in Q1 2021, an estimated $48M increase.
- Michael Gelband's biggest Q1 2021 reduction was Microsoft, cutting an estimated $378M.
- Michael Gelband fully exited Alibaba in Q1 2021, selling an estimated $258M.
- Michael Gelband's ten largest holdings make up 26% of its $6.86B portfolio in Q1 2021.
- Michael Gelband opened 973 new positions and closed 811 in Q1 2021.
- Michael Gelband's portfolio value fell 33% quarter-over-quarter to $6.86B.
Based on ExodusPoint Capital Management's 13F filing for Q1 2021, filed 17 May 2021.